07:00 , Apr 24, 2006 |  BioCentury  |  Finance

Ebb & Flow

Acqua Capital marked its return to biotech investing last week with its largest ever financing facility - a $200 million equity line for cardiovascular play CV Therapeutics (CVTX). Although the deal was with a longtime...